Explore
Validate
LearnABIN261167
antibody from antibodies-online
Targeting: WRAP53
FLJ10385, TCAB1, WDR79
Western blot
Immunocytochemistry Immunoprecipitation Immunohistochemistry Chromatin ImmunoprecipitationAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN261167 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-WD Repeat Containing, Antisense To TP53 (WRAP53) (AA 1-50) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 1-50
- Vial size
- 0.1 mL
- Storage
- Store at 4°C. Do not freeze.
- Handling
- Do not freeze.
Submitted references Minimized human telomerase maintains telomeres and resolves endogenous roles of H/ACA proteins, TCAB1, and Cajal bodies.
Human regulator of telomere elongation helicase 1 (RTEL1) is required for the nuclear and cytoplasmic trafficking of pre-U2 RNA.
Dynamics of Human Telomerase Holoenzyme Assembly and Subunit Exchange across the Cell Cycle.
TCAB1: a potential target for diagnosis and therapy of head and neck carcinomas.
Telomerase recruitment requires both TCAB1 and Cajal bodies independently.
WRAP53 promotes cancer cell survival and is a potential target for cancer therapy.
Vogan JM, Zhang X, Youmans DT, Regalado SG, Johnson JZ, Hockemeyer D, Collins K
eLife 2016 Aug 15;5
eLife 2016 Aug 15;5
Human regulator of telomere elongation helicase 1 (RTEL1) is required for the nuclear and cytoplasmic trafficking of pre-U2 RNA.
Schertzer M, Jouravleva K, Perderiset M, Dingli F, Loew D, Le Guen T, Bardoni B, de Villartay JP, Revy P, Londoño-Vallejo A
Nucleic acids research 2015 Feb 18;43(3):1834-47
Nucleic acids research 2015 Feb 18;43(3):1834-47
Dynamics of Human Telomerase Holoenzyme Assembly and Subunit Exchange across the Cell Cycle.
Vogan JM, Collins K
The Journal of biological chemistry 2015 Aug 28;290(35):21320-35
The Journal of biological chemistry 2015 Aug 28;290(35):21320-35
TCAB1: a potential target for diagnosis and therapy of head and neck carcinomas.
Sun CK, Luo XB, Gou YP, Hu L, Wang K, Li C, Xiang ZT, Zhang P, Kong XL, Zhang CL, Yang Q, Li J, Xiao LY, Li Y, Chen QM
Molecular cancer 2014 Jul 28;13:180
Molecular cancer 2014 Jul 28;13:180
Telomerase recruitment requires both TCAB1 and Cajal bodies independently.
Stern JL, Zyner KG, Pickett HA, Cohen SB, Bryan TM
Molecular and cellular biology 2012 Jul;32(13):2384-95
Molecular and cellular biology 2012 Jul;32(13):2384-95
WRAP53 promotes cancer cell survival and is a potential target for cancer therapy.
Mahmoudi S, Henriksson S, Farnebo L, Roberg K, Farnebo M
Cell death & disease 2011 Jan 13;2:e114
Cell death & disease 2011 Jan 13;2:e114
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
